The company sales for the twelve months of 2011 are approximately $21,000,000, which is an increase of 425%, compared to all of 2010 sales of $4,000,000, the company said.
The nutritional supplement company expects to report a net operating loss and a loss associated with convertible financing derivatives for the three months ended 31December 2011.
MusclePharm CEO Brad Pyatt said their expanding product line and distribution combined with their brand recognition positions them for accelerated growth over the coming months.